The US Patent and Trademark Office (USPTO) will issue Patent No. 8,340,916 to Sequenom for its application covering methods of detecting fetal aneuploidy.
The patent, which will be issued on 25 December 2012, covers claims related to methods for detecting fetal aneuploidy using massively parallel sequencing.
The patent is entitled as ‘Diagnosing Fetal Chromosomal Aneuploidy Using Massively Parallel Genomic Sequencing."
Sequenom, a life sciences company, is involved in providing genetic analysis solutions for improving healthcare.
In addition, the company develops new technology and diagnostic tests which are designed for use in molecular diagnostics discovery and clinical research.